Arialys Therapeutics
La Jolla
About Arialys Therapeutics
Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience. The company focuses on how the immune system impacts CNS health, disease, and treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $87.1M
- Last round: Series Unknown (Jun 2025)
- Website: arialysrx.com
Industries & Categories
Health Care, Medical, Neuroscience, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/arialys-therapeutics-49692 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.